Symbols / NUWE $1.10 +4.74% Nuwellis, Inc.
NUWE Chart
About
Nuwellis, Inc., a medical device company, develops, manufactures, and commercializes medical devices used in ultrafiltration therapy. The company provides Aquadex FlexFlow and Aquadex SmartFlow systems, which are used to treat patients suffering from fluid overload due to heart failure. Its Aquadex FlexFlow system includes a console, disposable blood circuit set, and disposable catheter. The company sells its products to hospitals and clinics through its direct salesforce in the United States; and through specialty healthcare distributors in Austria, Belarus, Brazil, Colombia, the Czech Republic, Germany, Greece, Hong Kong, India, Indonesia, Israel, Italy, Panama, Romania, Singapore, Slovakia, Spain, Switzerland, Thailand, the United Arab Emirates, and the United Kingdom. The company was formerly known as CHF Solutions, Inc. and changed its name to Nuwellis, Inc. in April 2021. Nuwellis, Inc. was founded in 1999 and is headquartered in Eden Prairie, Minnesota.
Fundamentals
Scroll to Statements| Sector | Healthcare | Industry | Medical Devices | Market Cap | 2.54M |
| Enterprise Value | 1.77M | Income | -17.52M | Sales | 8.27M |
| Book/sh | 1.56 | Cash/sh | 0.47 | Dividend Yield | — |
| Payout | 0.00% | Employees | 38 | IPO | — |
| P/E | — | Forward P/E | -0.42 | PEG | — |
| P/S | 0.31 | P/B | 0.71 | P/C | — |
| EV/EBITDA | -0.16 | EV/Sales | 0.21 | Quick Ratio | 0.85 |
| Current Ratio | 1.71 | Debt/Eq | 12.47 | LT Debt/Eq | — |
| EPS (ttm) | -25.39 | EPS next Y | -2.59 | EPS Growth | — |
| Revenue Growth | 4.40% | Earnings | 2026-05-12 | ROA | -86.86% |
| ROE | -3.83% | ROIC | — | Gross Margin | 61.96% |
| Oper. Margin | -100.78% | Profit Margin | -211.86% | Shs Outstand | 2.31M |
| Shs Float | 2.28M | Short Float | 1.31% | Short Ratio | 0.40 |
| Short Interest | — | 52W High | 45.36 | 52W Low | 0.96 |
| Beta | 0.08 | Avg Volume | 2.19M | Volume | 25.76K |
| Target Price | — | Recom | None | Prev Close | $1.05 |
| Price | $1.10 | Change | 4.74% |
Valuation Models
Price estimates from analyst targets and simple models.
Ratings
Latest analyst rating changes
| Date | Action | Analyst | Rating Change | Price Target |
|---|---|---|---|---|
| 2024-08-13 | reit | Roth MKM | Buy → Buy | $17 |
| 2024-07-29 | init | Roth MKM | — → Buy | $17 |
| 2023-11-08 | down | Ladenburg Thalmann | Buy → Neutral | — |
- South Texas hospitals get dedicated Nuwellis team for fluid care - Stock Titan ue, 07 Apr 2026 12
- Nuwellis (NUWE) Expands Commercial Reach in South Texas - GuruFocus ue, 07 Apr 2026 15
- Here’s Why Nuwellis Stock (NUWE) Rocketed Today - TipRanks ue, 27 Jan 2026 08
- Is Nuwellis Stock Built to Withstand More Downside? - Trefis Wed, 24 Dec 2025 08
- Nuwellis stock falls after CFO appointment announcement - Investing.com Fri, 30 Jan 2026 08
- Nuwellis (NASDAQ: NUWE) outlines 2026 virtual meeting, director elections and auditor ratification - Stock Titan hu, 02 Apr 2026 21
- Breakout Watch: Is NUWE stock trending bullish - Market Performance Recap & AI Enhanced Trade Execution Alerts - baoquankhu1.vn Mon, 06 Apr 2026 15
- NUWE Stock: How This $2 Microcap Secured An Infant Healthcare Monopoly - Nuwellis (NASDAQ:NUWE) - Benzinga ue, 27 Jan 2026 08
- Nuwellis, Inc. Q4 2025 Earnings Call Summary - Yahoo Finance ue, 10 Mar 2026 07
- Morning Market Movers: NUWE, PHGE, BNAI, BZAI See Big Swings - RTTNews ue, 27 Jan 2026 08
- Nuwellis Inc (NUWE) Stock Price & 30 Year Financial Data - GuruFocus Fri, 27 Mar 2026 06
- Former Nuwellis (NASDAQ: NUWE) directors submit response letters - Stock Titan Wed, 01 Apr 2026 20
- Half of Nuwellis U.S. revenue now comes from pediatric care - Stock Titan ue, 31 Mar 2026 12
- Heart failure and pediatric growth lift Nuwellis Q4 as console demand jumps 208% - Stock Titan ue, 10 Mar 2026 07
- [8-K] Nuwellis, Inc. Reports Material Event - Stock Titan Fri, 27 Mar 2026 07
Financials
| Line Item | Trend | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|---|
| Total Revenue |
|
8.27
-5.38%
|
8.74
-1.40%
|
8.86
+3.76%
|
8.54
|
| Operating Revenue |
|
8.27
-5.38%
|
8.74
-1.40%
|
8.86
+3.76%
|
8.54
|
| Cost Of Revenue |
|
3.15
+2.68%
|
3.06
-21.05%
|
3.88
+2.46%
|
3.79
|
| Reconciled Cost Of Revenue |
|
3.15
+2.68%
|
3.06
-21.05%
|
3.88
+2.46%
|
3.79
|
| Gross Profit |
|
5.12
-9.73%
|
5.68
+13.91%
|
4.98
+4.79%
|
4.75
|
| Operating Expense |
|
16.23
-2.60%
|
16.66
-26.31%
|
22.61
+3.13%
|
21.93
|
| Research And Development |
|
2.71
-15.49%
|
3.21
-40.82%
|
5.42
+24.87%
|
4.34
|
| Selling General And Administration |
|
13.52
+0.47%
|
13.46
-21.73%
|
17.19
-2.23%
|
17.58
|
| Total Expenses |
|
19.38
-1.78%
|
19.73
-25.54%
|
26.49
+3.03%
|
25.71
|
| Operating Income |
|
-11.11
-1.07%
|
-10.99
+37.67%
|
-17.63
-2.67%
|
-17.17
|
| Total Operating Income As Reported |
|
-11.11
-1.07%
|
-10.99
+37.67%
|
-17.63
-2.67%
|
-17.17
|
| EBITDA |
|
-6.55
-24.85%
|
-5.24
+67.94%
|
-16.36
-234.00%
|
-4.90
|
| Normalized EBITDA |
|
-10.68
+0.73%
|
-10.76
+37.14%
|
-17.11
-2.33%
|
-16.72
|
| Reconciled Depreciation |
|
0.42
+34.52%
|
0.31
-14.36%
|
0.36
-2.69%
|
0.37
|
| EBIT |
|
-6.96
-25.39%
|
-5.55
+66.78%
|
-16.72
-217.29%
|
-5.27
|
| Total Unusual Items |
|
4.13
-25.06%
|
5.51
+627.57%
|
0.76
-93.59%
|
11.83
|
| Total Unusual Items Excluding Goodwill |
|
4.13
-25.06%
|
5.51
+627.57%
|
0.76
-93.59%
|
11.83
|
| Special Income Charges |
|
0.00
-100.00%
|
0.90
|
0.00
|
—
|
| Other Special Charges |
|
—
|
-0.90
|
—
|
—
|
| Net Income |
|
-17.52
-56.93%
|
-11.16
+44.75%
|
-20.21
-39.13%
|
-14.53
|
| Pretax Income |
|
-17.52
-56.95%
|
-11.16
+44.76%
|
-20.20
-39.16%
|
-14.52
|
| Net Non Operating Interest Income Expense |
|
-10.55
-88.21%
|
-5.61
-60.98%
|
-3.48
+62.33%
|
-9.25
|
| Interest Expense Non Operating |
|
10.55
+88.21%
|
5.61
+60.98%
|
3.48
-62.33%
|
9.25
|
| Net Interest Income |
|
-10.55
-88.21%
|
-5.61
-60.98%
|
-3.48
+62.33%
|
-9.25
|
| Interest Expense |
|
10.55
+88.21%
|
5.61
+60.98%
|
3.48
-62.33%
|
9.25
|
| Other Income Expense |
|
4.14
-23.77%
|
5.43
+495.94%
|
0.91
-92.34%
|
11.90
|
| Other Non Operating Income Expenses |
|
0.01
+112.50%
|
-0.08
-151.95%
|
0.15
+105.33%
|
0.07
|
| Gain On Sale Of Security |
|
4.13
-10.44%
|
4.62
+508.84%
|
0.76
-93.59%
|
11.83
|
| Tax Provision |
|
0.01
+0.00%
|
0.01
-37.50%
|
0.01
-11.11%
|
0.01
|
| Tax Rate For Calcs |
|
0.00
+0.00%
|
0.00
+0.00%
|
0.00
+0.00%
|
0.00
|
| Tax Effect Of Unusual Items |
|
0.87
-25.06%
|
1.16
+627.57%
|
0.16
-93.59%
|
2.48
|
| Net Income Including Noncontrolling Interests |
|
-17.52
-56.93%
|
-11.16
+44.75%
|
-20.21
-39.13%
|
-14.53
|
| Net Income From Continuing Operation Net Minority Interest |
|
-17.52
-56.93%
|
-11.16
+44.75%
|
-20.21
-39.13%
|
-14.53
|
| Net Income From Continuing And Discontinued Operation |
|
-17.52
-56.93%
|
-11.16
+44.75%
|
-20.21
-39.13%
|
-14.53
|
| Net Income Continuous Operations |
|
-17.52
-56.93%
|
-11.16
+44.75%
|
-20.21
-39.13%
|
-14.53
|
| Normalized Income |
|
-20.79
-33.91%
|
-15.52
+25.40%
|
-20.81
+12.82%
|
-23.87
|
| Net Income Common Stockholders |
|
-17.52
-64.88%
|
-10.62
+53.05%
|
-22.63
-55.78%
|
-14.53
|
| Diluted EPS |
|
-25.39
+92.81%
|
-353.22
+97.91%
|
-16,934.40
-1686.71%
|
-947.80
|
| Basic EPS |
|
-25.39
+92.81%
|
-353.22
+97.91%
|
-16,934.40
-1686.71%
|
-947.80
|
| Basic Average Shares |
|
0.69
+2083.93%
|
0.03
+2265.34%
|
0.00
+267.03%
|
0.00
|
| Diluted Average Shares |
|
0.69
+2083.93%
|
0.03
+2265.34%
|
0.00
+267.03%
|
0.00
|
| Diluted NI Availto Com Stockholders |
|
-17.52
-64.88%
|
-10.62
+53.05%
|
-22.63
-55.78%
|
-14.53
|
| Preferred Stock Dividends |
|
-0.00
+99.26%
|
-0.54
-122.37%
|
2.42
|
—
|
| Line Item | Trend | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|---|
| Total Assets |
|
6.12
-37.98%
|
9.86
+0.96%
|
9.77
-60.40%
|
24.67
|
| Current Assets |
|
5.19
-41.43%
|
8.86
+7.87%
|
8.21
-63.95%
|
22.77
|
| Cash Cash Equivalents And Short Term Investments |
|
1.08
-78.70%
|
5.09
+34.08%
|
3.80
-79.24%
|
18.31
|
| Cash And Cash Equivalents |
|
1.08
-78.70%
|
5.09
+34.08%
|
3.80
-78.58%
|
17.74
|
| Other Short Term Investments |
|
—
|
—
|
0.00
-100.00%
|
0.57
|
| Receivables |
|
1.49
-13.55%
|
1.73
-11.48%
|
1.95
+38.76%
|
1.41
|
| Accounts Receivable |
|
1.49
-13.55%
|
1.73
-11.48%
|
1.95
+38.76%
|
1.41
|
| Inventory |
|
1.91
+11.18%
|
1.72
-13.97%
|
2.00
-24.95%
|
2.66
|
| Raw Materials |
|
1.46
+11.22%
|
1.31
-11.01%
|
1.47
-8.51%
|
1.61
|
| Work In Process |
|
0.09
-32.82%
|
0.13
-36.71%
|
0.21
+1.47%
|
0.20
|
| Finished Goods |
|
0.45
-13.09%
|
0.51
+30.28%
|
0.39
-60.42%
|
0.99
|
| Other Current Assets |
|
0.70
+121.59%
|
0.32
-31.67%
|
0.46
+16.41%
|
0.40
|
| Total Non Current Assets |
|
0.93
-7.63%
|
1.01
-35.36%
|
1.56
-18.01%
|
1.90
|
| Net PPE |
|
0.66
-33.10%
|
0.99
-31.44%
|
1.44
-23.47%
|
1.88
|
| Gross PPE |
|
4.64
-2.66%
|
4.77
-3.19%
|
4.92
-2.59%
|
5.05
|
| Accumulated Depreciation |
|
-3.98
-5.29%
|
-3.78
-8.50%
|
-3.48
-9.81%
|
-3.17
|
| Properties |
|
0.00
|
0.00
|
0.00
|
0.00
|
| Machinery Furniture Equipment |
|
1.07
+0.47%
|
1.07
+0.38%
|
1.06
-2.83%
|
1.09
|
| Other Properties |
|
3.31
-3.83%
|
3.45
-4.46%
|
3.61
-2.70%
|
3.71
|
| Leases |
|
0.25
+0.00%
|
0.25
+0.00%
|
0.25
+0.00%
|
0.25
|
| Other Non Current Assets |
|
0.27
+1190.48%
|
0.02
-82.50%
|
0.12
+471.43%
|
0.02
|
| Total Liabilities Net Minority Interest |
|
3.49
+4.62%
|
3.33
-49.17%
|
6.56
-46.74%
|
12.32
|
| Current Liabilities |
|
3.03
+18.48%
|
2.56
-19.33%
|
3.17
-32.34%
|
4.69
|
| Payables And Accrued Expenses |
|
2.23
+35.73%
|
1.64
-31.09%
|
2.38
+6.01%
|
2.25
|
| Payables |
|
2.23
+35.73%
|
1.64
-31.09%
|
2.38
+6.01%
|
2.25
|
| Accounts Payable |
|
2.23
+35.73%
|
1.64
-31.09%
|
2.38
+6.01%
|
2.25
|
| Pensionand Other Post Retirement Benefit Plans Current |
|
0.46
-28.13%
|
0.64
+21.90%
|
0.53
-75.71%
|
2.16
|
| Current Debt And Capital Lease Obligation |
|
0.26
+9.66%
|
0.24
+10.19%
|
0.22
-3.57%
|
0.22
|
| Current Capital Lease Obligation |
|
0.26
+9.66%
|
0.24
+10.19%
|
0.22
-3.57%
|
0.22
|
| Other Current Liabilities |
|
0.09
+107.32%
|
0.04
-19.61%
|
0.05
-12.07%
|
0.06
|
| Total Non Current Liabilities Net Minority Interest |
|
0.46
-41.16%
|
0.78
-77.12%
|
3.39
-55.60%
|
7.63
|
| Long Term Debt And Capital Lease Obligation |
|
0.07
-78.18%
|
0.31
-43.57%
|
0.54
-28.42%
|
0.76
|
| Long Term Capital Lease Obligation |
|
0.07
-78.18%
|
0.31
-43.57%
|
0.54
-28.42%
|
0.76
|
| Other Non Current Liabilities |
|
—
|
—
|
—
|
—
|
| Stockholders Equity |
|
2.63
-59.72%
|
6.53
+103.36%
|
3.21
-74.01%
|
12.36
|
| Common Stock Equity |
|
2.62
-59.80%
|
6.53
+118.33%
|
2.99
-75.80%
|
12.36
|
| Capital Stock |
|
0.01
+200.00%
|
0.00
-99.10%
|
0.22
|
0.00
|
| Common Stock |
|
0.00
|
0.00
|
0.00
|
0.00
|
| Preferred Stock |
|
0.01
+200.00%
|
0.00
-99.10%
|
0.22
|
0.00
|
| Share Issued |
|
1.69
+1519.15%
|
0.10
+2594.49%
|
0.00
+961.81%
|
0.00
|
| Ordinary Shares Number |
|
1.69
+1519.15%
|
0.10
+2594.49%
|
0.00
+961.81%
|
0.00
|
| Additional Paid In Capital |
|
318.93
+4.44%
|
305.37
+5.06%
|
290.65
+3.90%
|
279.74
|
| Retained Earnings |
|
-316.31
-5.86%
|
-298.79
-3.88%
|
-287.63
-7.56%
|
-267.42
|
| Gains Losses Not Affecting Retained Earnings |
|
0.01
+117.02%
|
-0.05
-51.61%
|
-0.03
-181.58%
|
0.04
|
| Other Equity Adjustments |
|
—
|
—
|
—
|
0.06
|
| Total Equity Gross Minority Interest |
|
2.63
-59.72%
|
6.53
+103.36%
|
3.21
-74.01%
|
12.36
|
| Total Capitalization |
|
2.63
-59.72%
|
6.53
+103.36%
|
3.21
-74.01%
|
12.36
|
| Working Capital |
|
2.15
-65.79%
|
6.30
+25.00%
|
5.04
-72.14%
|
18.08
|
| Invested Capital |
|
2.62
-59.80%
|
6.53
+118.33%
|
2.99
-75.80%
|
12.36
|
| Total Debt |
|
0.33
-39.82%
|
0.55
-28.29%
|
0.76
-22.76%
|
0.98
|
| Capital Lease Obligations |
|
0.33
-39.82%
|
0.55
-28.29%
|
0.76
-22.76%
|
0.98
|
| Net Tangible Assets |
|
2.63
-59.72%
|
6.53
+103.36%
|
3.21
-74.01%
|
12.36
|
| Tangible Book Value |
|
2.62
-59.80%
|
6.53
+118.33%
|
2.99
-75.80%
|
12.36
|
| Derivative Product Liabilities |
|
0.39
-16.88%
|
0.47
-83.54%
|
2.84
-58.61%
|
6.87
|
| Foreign Currency Translation Adjustments |
|
0.01
+117.02%
|
-0.05
-51.61%
|
-0.03
-72.22%
|
-0.02
|
| Inventories Adjustments Allowances |
|
-0.08
+65.96%
|
-0.23
-213.33%
|
-0.07
+48.28%
|
-0.14
|
| Preferred Stock Equity |
|
0.01
+200.00%
|
0.00
-99.10%
|
0.22
|
—
|
| Unrealized Gain Loss |
|
—
|
—
|
—
|
0.06
|
| Line Item | Trend | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|---|
| Operating Cash Flow |
|
-10.81
-12.71%
|
-9.59
+46.53%
|
-17.94
-18.40%
|
-15.15
|
| Cash Flow From Continuing Operating Activities |
|
-10.81
-12.71%
|
-9.59
+46.53%
|
-17.94
-18.40%
|
-15.15
|
| Net Income From Continuing Operations |
|
-17.52
-56.93%
|
-11.16
+44.75%
|
-20.21
-39.13%
|
-14.53
|
| Depreciation Amortization Depletion |
|
0.42
+34.52%
|
0.31
-14.36%
|
0.36
-2.69%
|
0.37
|
| Depreciation |
|
0.42
+34.52%
|
0.31
|
—
|
—
|
| Depreciation And Amortization |
|
0.42
+34.52%
|
0.31
-14.36%
|
0.36
-2.69%
|
0.37
|
| Other Non Cash Items |
|
10.55
+88.21%
|
5.61
+60.98%
|
3.48
-62.33%
|
9.25
|
| Stock Based Compensation |
|
0.13
-73.43%
|
0.48
-28.66%
|
0.67
-22.27%
|
0.86
|
| Operating Gains Losses |
|
-4.13
+8.48%
|
-4.52
-448.72%
|
-0.82
+92.97%
|
-11.70
|
| Gain Loss On Investment Securities |
|
-4.13
+10.44%
|
-4.62
-460.75%
|
-0.82
+92.97%
|
-11.70
|
| Net Foreign Currency Exchange Gain Loss |
|
—
|
—
|
—
|
—
|
| Gain Loss On Sale Of PPE |
|
0.00
-100.00%
|
0.10
|
0.00
|
—
|
| Change In Working Capital |
|
-0.25
+17.05%
|
-0.30
+78.52%
|
-1.42
-337.46%
|
0.60
|
| Change In Receivables |
|
0.23
+4.46%
|
0.22
+141.10%
|
-0.55
+16.92%
|
-0.66
|
| Changes In Account Receivables |
|
0.23
+4.46%
|
0.22
+141.10%
|
-0.55
+16.92%
|
-0.66
|
| Change In Inventory |
|
-0.19
-168.82%
|
0.28
-59.97%
|
0.70
+397.86%
|
0.14
|
| Change In Payables And Accrued Expense |
|
0.41
+164.86%
|
-0.63
+58.27%
|
-1.50
-217.37%
|
1.28
|
| Change In Other Working Capital |
|
-0.17
-686.36%
|
-0.02
-214.29%
|
-0.01
+92.71%
|
-0.10
|
| Change In Other Current Assets |
|
-0.53
-230.00%
|
-0.16
-146.15%
|
-0.07
+4.41%
|
-0.07
|
| Investing Cash Flow |
|
-0.09
-50.00%
|
-0.06
-118.18%
|
0.33
-97.76%
|
14.73
|
| Cash Flow From Continuing Investing Activities |
|
-0.09
-50.00%
|
-0.06
-118.18%
|
0.33
-97.76%
|
14.73
|
| Net PPE Purchase And Sale |
|
-0.09
-50.00%
|
-0.06
+59.73%
|
-0.15
-22.13%
|
-0.12
|
| Purchase Of PPE |
|
-0.09
-50.00%
|
-0.06
+59.73%
|
-0.15
-22.13%
|
-0.12
|
| Sale Of PPE |
|
—
|
—
|
—
|
—
|
| Capital Expenditure |
|
-0.09
-50.00%
|
-0.06
+75.81%
|
-0.25
-103.28%
|
-0.12
|
| Net Investment Purchase And Sale |
|
—
|
0.00
-100.00%
|
0.58
-96.11%
|
14.85
|
| Purchase Of Investment |
|
—
|
—
|
—
|
0.00
|
| Sale Of Investment |
|
—
|
0.00
-100.00%
|
0.58
-96.11%
|
14.85
|
| Net Intangibles Purchase And Sale |
|
—
|
0.00
+100.00%
|
-0.10
|
0.00
|
| Purchase Of Intangibles |
|
—
|
0.00
+100.00%
|
-0.10
|
0.00
|
| Financing Cash Flow |
|
6.94
-36.69%
|
10.96
+197.64%
|
3.68
-60.91%
|
9.42
|
| Cash Flow From Continuing Financing Activities |
|
6.94
-36.69%
|
10.96
+197.64%
|
3.68
-60.91%
|
9.42
|
| Net Issuance Payments Of Debt |
|
—
|
0.00
+100.00%
|
-0.03
-7.69%
|
-0.03
|
| Repayment Of Debt |
|
—
|
0.00
+100.00%
|
-0.03
-7.69%
|
-0.03
|
| Long Term Debt Payments |
|
—
|
0.00
+100.00%
|
-0.03
-7.69%
|
-0.03
|
| Net Long Term Debt Issuance |
|
—
|
0.00
+100.00%
|
-0.03
-7.69%
|
-0.03
|
| Net Common Stock Issuance |
|
6.94
-12.45%
|
7.93
+275.87%
|
2.11
-77.68%
|
9.45
|
| Proceeds From Stock Option Exercised |
|
0.00
-100.00%
|
2.53
+2011.67%
|
0.12
|
0.00
|
| Changes In Cash |
|
-3.96
-402.06%
|
1.31
+109.42%
|
-13.92
-254.68%
|
9.00
|
| Effect Of Exchange Rate Changes |
|
0.06
+443.75%
|
-0.02
-23.08%
|
-0.01
-85.71%
|
-0.01
|
| Beginning Cash Position |
|
5.09
+34.08%
|
3.80
-78.58%
|
17.74
+102.89%
|
8.74
|
| End Cash Position |
|
1.19
-76.64%
|
5.09
+34.08%
|
3.80
-78.58%
|
17.74
|
| Free Cash Flow |
|
-10.90
-12.94%
|
-9.65
+46.93%
|
-18.18
-19.08%
|
-15.27
|
| Income Tax Paid Supplemental Data |
|
0.01
+0.00%
|
0.01
-41.67%
|
0.01
+33.33%
|
0.01
|
| Common Stock Issuance |
|
6.94
-12.45%
|
7.93
+275.87%
|
2.11
-77.68%
|
9.45
|
| Issuance Of Capital Stock |
|
6.94
-17.66%
|
8.43
+134.70%
|
3.59
-62.00%
|
9.45
|
| Net Preferred Stock Issuance |
|
0.00
-100.00%
|
0.50
-66.19%
|
1.48
|
0.00
|
| Preferred Stock Issuance |
|
0.00
-100.00%
|
0.50
-66.19%
|
1.48
|
0.00
|
SEC Filings
Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.
- 8-K2026-03-27 View
- 8-K2026-03-17 View
- 10-K2026-03-11 View
- 8-K2026-03-10 View
- 8-K2026-02-26 View
- 8-K2026-01-30 View
- 8-K2026-01-23 View
- 10-Q2025-11-12 View
- 8-K2025-11-12 View
- 8-K2025-10-08 View
- 8-K2025-09-30 View
- 8-K2025-09-18 View
- 8-K2025-09-09 View
- 8-K2025-09-03 View
- 8-K2025-08-21 View
- 8-K2025-08-19 View
- 10-Q2025-08-14 View
- 8-K2025-08-14 View
- 8-K2025-08-04 View
- 8-K2025-07-23 View
Trades
| Date | User | Broker | Pattern | Type | Position Size | Entry Price | Trade P&L | Status |
|---|
Posts
| Published | Title | Author | Category |
|---|